Heba F. Salem

IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Ahmed Sadik, Luis F. Somarribas Patterson, Selcen Öztürk et al. · Cell · 2020 · 540 citations · Full text

5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment

Rasha A. Khallaf, Heba F. Salem, Ahmed Abdelbary · Drug Delivery · 2016 · 106 citations

<i>In vitro</i>/<i>in vivo</i> evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids

Eman Maher, Ahmed Mahmoud Abdelhaleem Ali, Heba F. Salem et al. · Drug Delivery · 2016 · 86 citations · Full text

Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study

Heba F. Salem, Rasha M. Kharshoum, Heba A. Abou‐Taleb et al. · AAPS PharmSciTech · 2019 · 86 citations

Cell-based Drug Delivery, Nanomedicine, Drug Targeting +9

Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition

Rofaida Gaballa, Hamdy Ali, Mohamed O. Mahmoud et al. · Cancers · 2020 · 85 citations · Full text

Androgen Receptor, Exosomes-mediated Transfer, Prostate Cancer Cells +20